GMED Earnings & Financial Statements
Globus Medical, Inc.
$76.43
-$0.14(-0.18%)
64
Overall
80
Value
50
Tech
63
Quality
Market Cap
$10.28B
Volume
1.57M
52W Range
$56.50 - $101.40
Target Price
$101.07
GMED earnings and financial statements: Globus Medical, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
GMED Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $2.94B | $2.52B | $1.57B | $1.02B | $958.10M |
| Cost of revenue | $957.80M | $1.04B | $548.17M | $263.73M | $239.22M |
| Operating income | $479.82M | $165.99M | $133.14M | $227.95M | $171.95M |
| EBITDA | $874.77M | $378.30M | $290.00M | $297.04M | $264.73M |
| Net income | $537.87M | $102.98M | $122.87M | $190.17M | $149.19M |
| EPS (diluted) | $3.92 | $0.75 | $1.07 | $1.85 | $1.44 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $5.30B | $5.25B | $5.09B | $2.08B | $1.96B |
| Total liabilities | $729.51M | $1.07B | $1.09B | $229.75M | $215.88M |
| Shareholders’ equity | $4.57B | $4.18B | $4.00B | $1.85B | $1.74B |
| Cash and equivalents | $526.16M | $784.44M | - | - | $26.68M |
| Long-term debt | $103.92M | $83.59M | $508.44M | $3.48M | - |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | $753.45M | $520.64M | $243.50M | $178.47M | $276.27M |
| Capital expenditure | -$174.43M | -$115.43M | -$78.27M | -$74.05M | -$56.90M |
| Free cash flow | $579.02M | $405.21M | $165.22M | $104.42M | $219.38M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | GMED | $76.43 | -0.2% | 1.57M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |